Danmark-København: Branchespecifik programmeludvikling

The Swedish Medical Products Agency (SMPA), together with the Danish Medicines Agency (DKMA) have established a horizontal collaboration regarding development, use and maintenance of a joint Pharmacovigilance Solution in order to fulfil their respective obligations under EU regulation as National Competent Agencies with respect to performance of pharmacovigilance activities. For this contract and on the execution of the procured bid, the DKMA will act as coordinator and provide leadership in completion of the work procured.The SMPA and the DKMA intends to productize and customize existing IT support for the management of adverse reactions and signals for human medicine and veterinary medicine. This contract has previously been published by the SMPA where it unfortunately did not attract any bidders and therefore we have now awarded it by means of a negotiated procedure.